Search research articles
Contact Us
Filters
Showing results (51-60 of 97) with videos related to
Page
of 10
Sort By:
Nuclear Medicine and Biology
|
August 1, 1997
The development of technetium-99m-labelled interleukin-2: a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseases
M Chianelli, A Signore, A R Fritzberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 16, 2000
99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide
C Decristoforo, L Melendez-Alafort, J K Sosabowski, et al.
Nuclear Medicine Communications
|
May 1, 1991
The design of a two-phase radiolabelled meal for gastric emptying studies
S J Mather, D Ellison, J Nightingale, et al.
Chemical Reviews
|
April 27, 2010
Molecular imaging of inflammation/infection: nuclear medicine and optical imaging agents and methods
A Signore, S J Mather, G Piaggio, et al.
Anaesthesia
|
January 1, 1981
Etomidate infusion: a method of sedation for the intensive care unit
D M Edbrooke, B S Hebron, S J Mather, et al.
Nuclear Medicine Communications
|
October 1, 1988
A rapid method for the preparation of 99Tcm hexametazime-labelled leucocytes
K K Solanki, S J Mather, M A Janabi, et al.
British Journal of Anaesthesia
|
April 1, 1983
Pharmacokinetics of etomidate associated with prolonged i.v. infusion
B S Hebron, D L Edbrooke, D M Newby, et al.
British Journal of Anaesthesia
|
April 1, 1990
Postoperative analgesia after paediatric orchidopexy: evaluation of a bupivacaine-morphine mixture
A R Wolf, D Hughes, A Wade, et al.
European Journal of Nuclear Medicine
|
September 28, 2000
99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives
C Decristoforo, S J Mather, W Cholewinski, et al.
European Journal of Nuclear Medicine
|
November 18, 2000
Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide
C Decristoforo, W Cholewinski, E Donnemiller, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 97) with videos related to
Sort By:
Page
of 10
Nuclear Medicine and Biology
|
August 1, 1997
The development of technetium-99m-labelled interleukin-2: a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseases
M Chianelli, A Signore, A R Fritzberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 16, 2000
99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide
C Decristoforo, L Melendez-Alafort, J K Sosabowski, et al.
Nuclear Medicine Communications
|
May 1, 1991
The design of a two-phase radiolabelled meal for gastric emptying studies
S J Mather, D Ellison, J Nightingale, et al.
Chemical Reviews
|
April 27, 2010
Molecular imaging of inflammation/infection: nuclear medicine and optical imaging agents and methods
A Signore, S J Mather, G Piaggio, et al.
Anaesthesia
|
January 1, 1981
Etomidate infusion: a method of sedation for the intensive care unit
D M Edbrooke, B S Hebron, S J Mather, et al.
Nuclear Medicine Communications
|
October 1, 1988
A rapid method for the preparation of 99Tcm hexametazime-labelled leucocytes
K K Solanki, S J Mather, M A Janabi, et al.
British Journal of Anaesthesia
|
April 1, 1983
Pharmacokinetics of etomidate associated with prolonged i.v. infusion
B S Hebron, D L Edbrooke, D M Newby, et al.
British Journal of Anaesthesia
|
April 1, 1990
Postoperative analgesia after paediatric orchidopexy: evaluation of a bupivacaine-morphine mixture
A R Wolf, D Hughes, A Wade, et al.
European Journal of Nuclear Medicine
|
September 28, 2000
99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives
C Decristoforo, S J Mather, W Cholewinski, et al.
European Journal of Nuclear Medicine
|
November 18, 2000
Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide
C Decristoforo, W Cholewinski, E Donnemiller, et al.
Page
of 10